OPTION CARE HEALTH INC (OPCH)
US68404L2016 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to OPCH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.16. This target is 78.58% above the current price.
OPCH was analyzed by 15 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about OPCH.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
OPCH was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-05 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2024-11-01 | Truist Securities | Maintains | Buy -> Buy |
| 2024-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-31 | Jefferies | Downgrade | Buy -> Hold |
| 2024-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-30 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-25 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-16 | JMP Securities | Initiate | Market Outperform |
| 2024-04-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-04 | Jefferies | Maintains | Buy -> Buy |
| 2024-02-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-07-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-06-27 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-05-05 | Barrington Research | Maintains | Outperform |
| 2023-05-05 | Deutsche Bank | Maintains | Buy |
| 2023-02-27 | Jefferies | Reiterate | Buy |
| 2022-10-28 | Barrington Research | Maintains | Outperform |
| 2022-08-22 | Goldman Sachs | Maintains | Buy |
| 2022-07-28 | Barrington Research | Maintains | Outperform |
| 2021-08-04 | Canaccord Genuity | Maintains | Buy |
| 2021-07-19 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2021-03-12 | Canaccord Genuity | Maintains | Buy |